Kronox Lab Sciences Limited (IN:KRONOX)
:KRONOX
Want to see IN:KRONOX full AI Analyst Report?
KRONOX Stock Chart & Stats
₹133.19
₹3.45(1.73%)
At close: 4:00 PM EST
₹133.19
₹3.45(1.73%)
Day’s Range― - ―
52-Week Range₹96.00 - ₹207.40
Previous CloseN/A
Volume58.78K
Average Volume (3M)4.31K
Market Cap
₹4.97B
Enterprise Value₹5.14B
Total Cash (Recent Filing)₹521.69M
Total Debt (Recent Filing)₹26.14M
Price to Earnings (P/E)18.0
Beta1.30
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.35%
Share Statistics
EPS (TTM)3.53
Shares Outstanding37,104,000
10 Day Avg. Volume5,373
30 Day Avg. Volume4,310
Financial Highlights & Ratios
PEG Ratio1.86
Price to Book (P/B)3.65
Price to Sales (P/S)4.19
P/FCF Ratio20.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Profitability And MarginsSustained high margins and rising net income indicate durable operating efficiency and pricing power in the specialty chemicals niche. Even with flat top-line, the company converted revenue into higher net profit, supporting long‑term earnings resilience and internal reinvestment capacity.
Conservatively Levered Balance SheetVery low leverage provides financial flexibility, lowers default risk, and supports capital allocation optionality over months. A strong equity base enables financing for capex or working capital from internal resources and preserves resilience through sector cycles.
Strong Operating And Free Cash GenerationHigh conversion of earnings to cash, particularly FY2025 where FCF approximated net income, signals quality of earnings and ability to self-fund growth, dividends, or debt reduction. Consistent positive cash flow underpins long‑term capital allocation and stability.
Bears Say
Decline In Operating And Free Cash FlowA material drop in operating and free cash flow signals rising working capital needs or higher investments that may pressure liquidity and constrain discretionary spending. If the trend persists, it can weaken the company's ability to fund growth internally or cushion downturns.
Stagnant And Inconsistent Revenue TrajectoryFlat top-line growth and inconsistent reported growth metrics limit visibility into sustainable demand expansion. Without durable revenue momentum, margins could be harder to sustain long-term and returns on invested capital may face pressure if revenue per fixed cost base doesn't improve.
Emerging Use Of Debt After Zero-debt YearThe move from zero debt to positive borrowings, albeit small, marks a shift in financing posture. If continued, incremental leverage could raise interest exposure and reduce flexibility, especially if cash flows weaken; warrants monitoring over coming quarters.
Kronox Lab Sciences Limited News
KRONOX FAQ
What was Kronox Lab Sciences Limited’s price range in the past 12 months?
Kronox Lab Sciences Limited lowest stock price was ₹96.00 and its highest was ₹207.40 in the past 12 months.
What is Kronox Lab Sciences Limited’s market cap?
Kronox Lab Sciences Limited’s market cap is ₹4.97B.
When is Kronox Lab Sciences Limited’s upcoming earnings report date?
Kronox Lab Sciences Limited’s upcoming earnings report date is Aug 17, 2026 which is in 73 days.
How were Kronox Lab Sciences Limited’s earnings last quarter?
Kronox Lab Sciences Limited released its earnings results on May 20, 2026. The company reported ₹2.18 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.18.
Is Kronox Lab Sciences Limited overvalued?
According to Wall Street analysts Kronox Lab Sciences Limited’s price is currently Overvalued.
Does Kronox Lab Sciences Limited pay dividends?
Kronox Lab Sciences Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.35%. See more information on Kronox Lab Sciences Limited dividends here
What is Kronox Lab Sciences Limited’s EPS estimate?
Kronox Lab Sciences Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kronox Lab Sciences Limited have?
Kronox Lab Sciences Limited has 37,104,000 shares outstanding.
What happened to Kronox Lab Sciences Limited’s price movement after its last earnings report?
Kronox Lab Sciences Limited reported an EPS of ₹2.18 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.453%.
Which hedge fund is a major shareholder of Kronox Lab Sciences Limited?
Currently, no hedge funds are holding shares in IN:KRONOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kronox Lab Sciences Limited
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specification, and specialty anhydrous, as well as heat treatment, quenching, eutectic salt. Kronox Lab Sciences Limited was incorporated in 2008 and is based in Vadodara, India.
Technical Analysis
Asahi Songwon Colors Ltd.
―
Chembond Chemicals Limited
―
DIC India Limited
―
Mangalam Organics Ltd
―
Poddar Pigments Limited
―